Navigation Links
Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy
Date:9/10/2013

itute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.

About Oncology at Bayer
Bayer is committed to delivering science for a better life by advancing a portfolio of innovative treatments. The oncology franchise at Bayer now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company's approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.

About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions.  As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare.  The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors in
'/>"/>

SOURCE Bayer HealthCare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Among the Novel Oral Anticoagulants, Bayer/Janssens Xarelto is Positioned To Be the Sales-Leading Therapy for Venous Thromboembolism (VTE)
2. FDA Advisory Committee Unanimously Recommends Approval Of Bayers Riociguat In Two Pulmonary Hypertension Indications
3. Statement: Bayer Mourns Passing of Senator Frank Lautenberg
4. Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
5. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
6. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
7. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
8. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
9. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
10. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
11. Bayer Consumer Care Voluntarily Recalls 56 Lots of BRONKAID Caplets Dual Action Formula due to Product Labeling Error
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... 2011 Cynosure, Inc. (Nasdaq: CYNO ), ... invasive and non-invasive aesthetic applications, today announced that two ... cellulite reduction have received key international regulatory clearances. ... License authorizing the sale in Canada of the company,s ...
... SANTA CLARA, Calif., March 15, 2011 NewCardio, Inc. (OTC Bulletin ... today that the Company expects to file its Form 10-K for ... management will conduct a conference call to provide a corporate update ... Corporate Update Conference Call When : 1:30 p.m. ...
Cached Medicine Technology:Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 2Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 3NewCardio to Conduct Corporate Update Conference Call on March 29, 2011 2
(Date:8/30/2014)... Saturday 30 August 2014: The first recommendations on ... pulmonary embolism are published today in new ESC ... by Professor Stavros V. Konstantinides (Germany/Greece) and Professor ... on the diagnosis and management of acute pulmonary ... Journal (1) and on the ESC Website. , ...
(Date:8/29/2014)... Indosoft, Inc. , a leading provider ... of its most advanced contact center product, Q-Suite 5.7.7. ... as well as updates to existing aspects of its ... on the presentation side has received an update with ... builder. This WYSIWYG editor allows admins to easily ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 According to ... a popular way to lose weight quickly, safely and naturally. ... it claims to be amazingly fast, too. , Daily ... new method will not only teach patients how to eliminate ... maintain the desired results when it comes to body modeling. ...
(Date:8/29/2014)... The new review that can be read on ... system that will permanently eliminate the symptoms of this disease. ... achieve a cure in as fast as 30 to 60 ... about one week. , The Tinnitus Miracle review indicates ... mild hearing loss, pain in the ear and dizziness. Read ...
(Date:8/29/2014)... Denver, CO (PRWEB) August 29, 2014 ... panic attack is the feeling of intense stress and ... entire life of the sufferer, causing insecurity and affecting ... numerous factors and there are many symptoms that patients ... stress are among these symptoms. Overcoming panic attacks is ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2
... survey conducted by the Scottish executives large numbers of Scots ... The researchers feel that memory loss is associated with long-term ... situations, becoming a target for rapists. ,This survey ... percentage was losing their memories as a result of alcohol. ...
... openness are the tenets that define ideal relationships, has anyone ... past sexual relationships? The need for such revelations, assumes ... ,Value system is one thing, but the dictates of law ... of toeing with legal procedures. So where is the ...
... which began in Jalgaon, on March 29, following fresh ... authorities along with the Maharashtra// Animal Husbandry Department officials ... from six tehsils in Jalgaon district. ,The ... 82 teams. According to Dr B K Wankhade, Regional ...
... Delhi High Court Monday issued notice to the National ... a public interest litigation seeking legal// sanction to homosexuality., ... of section 377 of the Indian Penal Code (IPC) ... offence and punishable with imprisonment up to 10 years., ...
... that the culling operations in Jalgoan where a fresh outbreak ... B K Wankhade, Regional District Commissioner, Animal Husbandry said that ... outbreak was reported ,500 health workers in 82 ... owners had been compensated to the tune of Rs 1 ...
... that immune system gets boosted in people who are prone ... risk of brain cancer. // ,"It appears that ... Scheurer, the study's lead author. "They seem to produce enough ... and working to prevent cancer from beginning to develop.", reports ...
Cached Medicine News:
Beta-2 Microglobulin EIA Lipid / Protein Quantification 025-BC-1061...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
Human Growth Hormone EIA Endocrine Function 025-BC-1033...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
Medicine Products: